5-hydroxytryptophan has been researched along with Tremor in 50 studies
5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Specific beta 1- and beta 2-adrenoceptor antagonists, acebutolol and butoxamine respectively were used to investigate the involvement of blockade of these receptors in the inhibition of harmaline-induced tremors." | 7.67 | Involvement of beta 2-adrenoceptor blockade and 5-hydroxytryptamine mechanism in inhibition of harmaline-induced tremors in rats. ( Paul, V, 1986) |
| "The tremors induced by harmine, LON-954 (N-carbamoyl-2-(2,6-dichlorophenyl)acetamidine hydrochloride) and 5-hydroxytryptophan (5-HTP) were studied in control rats and in rats withdrawn for 16-48 hrs from 6 to 9 days' ethanol administration." | 7.67 | Harmine-, LON-954- and 5-hydroxytryptophan-induced tremors in rats withdrawn from ethanol. ( Gothóni, P, 1985) |
| "Harmine, a hallucinogen with potent monoamine oxidase inhibitory properties, induced abnormal behavior, including tremor, scratching, head twitch and cage biting, in the mouse." | 7.66 | Pharmacological characteristics of abnormal behavior induced by harmine with special reference to tremor in mice. ( Fujiwara, M; Hashimoto, Y; Kataoka, Y; Kawanishi, K; Ueki, S, 1981) |
| "Phenoxybenzamine (5 mg/kg IP) and trazodone (5 mg/kg IP) reduced tremors produced in mice by administration of oxotremorine (10 mg/kg), harmaline (80 mg/kg), catechol (60 mg/kg), kepone (200 mg/kg) and clonidine (100 mg/kg)." | 7.66 | Serotonin-norepinephrine interactions in the tremorolytic actions of phenoxybenzamine and trazodone. ( Hwang, EC; van Woert, MH, 1979) |
| "The current study was aimed at investigating the effect of Areca catechu nut dichloromethane fraction (7 mg/kg) on monoamines (serotonin and dopamine) modulation (5-hydroxytryptophan-induced tremors and phenylethylamine-induced stereotypes) and its interaction with tyramine (cheese effect)." | 3.80 | Effect of dichloromethane fraction of Areca catechu nut on monoamines associated behaviors and tyramine pressor sensitivity in rodents. ( Abbas, G; Ahmed, FS; Dar, A; Khan, S; Rahman, A, 2014) |
| "In order to better define the role of 5-HT(1A) receptors in the modulation of extrapyramidal motor functions, we investigated the effect of 5-HT(1A) agonists on tacrine-induced tremulous jaw movements (TJM) in rats, a putative model of parkinsonian tremor." | 3.73 | In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties. ( Artaiz, I; Castro, E; Del Olmo, E; Innerárity, A; Labeaga, L; Orjales, A; Pazos, A; Zazpe, A, 2006) |
| "5 mg/kg it increased head-twitches and tremors induced by 1-5-hydroxytryptophan (4 mg/kg) and decreased the number of bites of a food pellet by mice which had been maintained on a water only diet for 24-27 h ('Tantale' test)." | 3.67 | Comparison of clenbuterol enantiomers using four psychopharmacological tests sensitive to beta-agonists. ( Brochet, D; Martin, P; Puech, AJ; Simon, P; Soubrié, P, 1985) |
| "The effects of two beta 2-adrenoceptor agonists with different lipophilicities were studied on tremor induced by L-5-hydroxytryptophan (L-5-HTP) in pargyline- and carbidopa-pretreated rats." | 3.67 | Central beta-adrenoceptors can modulate 5-hydroxytryptamine-induced tremor in rats. ( Hallberg, H, 1986) |
| "Specific beta 1- and beta 2-adrenoceptor antagonists, acebutolol and butoxamine respectively were used to investigate the involvement of blockade of these receptors in the inhibition of harmaline-induced tremors." | 3.67 | Involvement of beta 2-adrenoceptor blockade and 5-hydroxytryptamine mechanism in inhibition of harmaline-induced tremors in rats. ( Paul, V, 1986) |
| "The effect of beta-adrenoceptor antagonists, varying in lipophilicity and receptor selectivity, were studied on tremor elicited by L-5-hydroxytryptophan (L-5-HTP) in rats pretreated with a peripherally acting decarboxylase inhibitor and a monoamine oxidase inhibitor, or by the directly acting 5-HT agonist 5-methoxy-N,N-dimethyltryptamine (5-MeODMT)." | 3.67 | Blockade of central beta-adrenoceptors attenuates tremor induced by 5-hydroxytryptamine (5-HT)-receptor activation in rats. ( Hallberg, H, 1987) |
| "The tremors induced by harmine, LON-954 (N-carbamoyl-2-(2,6-dichlorophenyl)acetamidine hydrochloride) and 5-hydroxytryptophan (5-HTP) were studied in control rats and in rats withdrawn for 16-48 hrs from 6 to 9 days' ethanol administration." | 3.67 | Harmine-, LON-954- and 5-hydroxytryptophan-induced tremors in rats withdrawn from ethanol. ( Gothóni, P, 1985) |
| "Harmine, a hallucinogen with potent monoamine oxidase inhibitory properties, induced abnormal behavior, including tremor, scratching, head twitch and cage biting, in the mouse." | 3.66 | Pharmacological characteristics of abnormal behavior induced by harmine with special reference to tremor in mice. ( Fujiwara, M; Hashimoto, Y; Kataoka, Y; Kawanishi, K; Ueki, S, 1981) |
| "Phenoxybenzamine (5 mg/kg IP) and trazodone (5 mg/kg IP) reduced tremors produced in mice by administration of oxotremorine (10 mg/kg), harmaline (80 mg/kg), catechol (60 mg/kg), kepone (200 mg/kg) and clonidine (100 mg/kg)." | 3.66 | Serotonin-norepinephrine interactions in the tremorolytic actions of phenoxybenzamine and trazodone. ( Hwang, EC; van Woert, MH, 1979) |
| "A myoclonic syndrome consisting of tremor, myoclonus, and seizures was produced following the systemic administration of 5-hydroxytryptophan to adult rats previously given intracisternal injections of 5,7-dihydroxytryptamine and systemic desmethylimipramine, but not in their controls." | 3.65 | Myoclonus after 5-hydroxytryptophan in rats with lesions of indoleamine neurons in the central nervous system. ( Baldessarini, RJ; Cancian, D; Growdon, JH; Stewart, RM, 1976) |
| "Either L-dopa, in combination with 1-alpha-methyldopa hydrazine (MK-486), or 1-(2''-pyrimidyl)-4-piperonylpiperazine, an agent that stimulates dopamine receptors, relieves surgically induced tremor in monkeys and concomitantly evokes involuntary movements." | 3.65 | Tremor and involuntary movements in monkeys: effect of L-dopa and of a dopamine receptor stimulating agent. ( Anagnoste, B; Battista, AF; Fuxe, K; Goldstein, M; Ohmoto, T, 1973) |
| "25-8 mg/kg, SC) when dosed 15 min prior to either 5-MeODMT (4 mg/kg, SC) or 8-OH-DPAT (16 mg/kg, SC) blocked both RFT and HA in a dose-dependent manner, suggesting these 5-HT syndrome behaviors are mediated via 5-HT1A receptor activation." | 1.28 | 5-HT1A and 5-HT2 receptors mediate discrete behaviors in the Mongolian gerbil. ( Eison, AS; Wright, RN, 1992) |
| "Tremor was recorded and analysed by an objective method based on accelerometry." | 1.27 | Central beta-adrenoceptors can modulate 5-hydroxytryptamine-induced tremor in rats. ( Hallberg, H, 1986) |
| "Progress in the treatment of action myoclonus is especially noteworthy and has led to the implication of serotonin deficit in the pathophysiology of this syndrome." | 1.26 | New approaches in the management of hyperkinetic movement disorders. ( Fahn, S, 1977) |
| "In monkeys with resting tremor, the administration of DL-5-HTP (5-hydroxytryptophan) or of DL-DOPA (3,4-dihydroxyphenylalanine) relieves the tremor, but the simultaneous administration of DL-5-HTP or DL-DOPA and atropine results in a much more pronounced relief." | 1.25 | The effects of centrally acting drugs on tremor in monkeys with mesencephalic lesions. ( Anagnoste, B; Battista, AF; Goldstein, M; Nakatani, S, 1969) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 40 (80.00) | 18.7374 |
| 1990's | 5 (10.00) | 18.2507 |
| 2000's | 3 (6.00) | 29.6817 |
| 2010's | 2 (4.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, S | 1 |
| Abbas, G | 1 |
| Ahmed, FS | 1 |
| Rahman, A | 1 |
| Dar, A | 1 |
| Hayashi, Y | 1 |
| Jacob-Vadakot, S | 1 |
| Dugan, EA | 1 |
| McBride, S | 1 |
| Olexa, R | 1 |
| Simansky, K | 1 |
| Murray, M | 1 |
| Shumsky, JS | 1 |
| CAHN, J | 1 |
| HEROLD, M | 1 |
| BARRE, N | 1 |
| SCHNIEDEN, H | 1 |
| ROOS, BE | 1 |
| STEG, G | 1 |
| HANSSON, E | 1 |
| FLEMING, RM | 1 |
| CLARK, WG | 1 |
| Sánchez, C | 1 |
| Kreilgaard, M | 1 |
| Zazpe, A | 1 |
| Artaiz, I | 1 |
| Innerárity, A | 1 |
| Del Olmo, E | 1 |
| Castro, E | 1 |
| Labeaga, L | 1 |
| Pazos, A | 1 |
| Orjales, A | 1 |
| Kawanishi, K | 1 |
| Hashimoto, Y | 1 |
| Fujiwara, M | 1 |
| Kataoka, Y | 1 |
| Ueki, S | 1 |
| Katoh, A | 1 |
| Eigyo, M | 1 |
| Ishibashi, C | 1 |
| Naitoh, Y | 1 |
| Takeuchi, M | 1 |
| Ibii, N | 1 |
| Ikeda, M | 1 |
| Matsushita, A | 1 |
| Porsolt, RD | 1 |
| Roux, S | 1 |
| Drieu, K | 1 |
| Silvestrini, B | 1 |
| Lisciani, R | 1 |
| Motomatsu, T | 1 |
| Seidah, N | 1 |
| Chrétien, M | 1 |
| Fahn, S | 1 |
| Growdon, JH | 2 |
| Hwang, EC | 1 |
| van Woert, MH | 1 |
| Guillard, A | 1 |
| Chastang, C | 1 |
| Angst, J | 1 |
| Woggon, B | 1 |
| Schoepf, J | 1 |
| Carlsson, A | 1 |
| Stewart, RM | 1 |
| Cancian, D | 1 |
| Baldessarini, RJ | 1 |
| Mokler, DJ | 1 |
| Sullivan, SA | 1 |
| Winterson, BJ | 1 |
| Eison, AS | 1 |
| Wright, RN | 1 |
| Harhammer, R | 1 |
| Schäfer, U | 1 |
| Ott, T | 1 |
| Ray, SK | 1 |
| Poddar, MK | 1 |
| Martin, P | 2 |
| Puech, AJ | 1 |
| Brochet, D | 2 |
| Soubrié, P | 2 |
| Simon, P | 2 |
| Hallberg, H | 3 |
| Paul, V | 1 |
| Carlsson, L | 1 |
| Elg, R | 1 |
| Gothóni, P | 1 |
| Chase, TN | 1 |
| Tourian, AY | 1 |
| Omori, K | 1 |
| Kojima, T | 1 |
| Kelly, DM | 1 |
| Naylor, RJ | 1 |
| Weiner, WJ | 2 |
| Goetz, C | 2 |
| Westheimer, R | 2 |
| Klawans, HL | 2 |
| Sano, I | 1 |
| Taniguchi, K | 1 |
| Rodríguez, R | 1 |
| Guilleminault, C | 1 |
| Tharp, BR | 1 |
| Cousin, D | 1 |
| Everett, GM | 1 |
| Goldstein, M | 3 |
| Battista, AF | 3 |
| Ohmoto, T | 1 |
| Anagnoste, B | 3 |
| Fuxe, K | 1 |
| Nakatani, S | 2 |
| Yen, HC | 1 |
| Day, CA | 1 |
| Himwich, WA | 2 |
| Goldstein, SL | 1 |
| Fox, MW | 1 |
| Rovine, BW | 1 |
| Hadzović, S | 1 |
| Ernst, AM | 1 |
| Kim, JS | 1 |
| Hassler, R | 1 |
| Kurokawa, M | 1 |
| Bak, IJ | 1 |
| Goldstein, S | 1 |
| Leiner, K | 1 |
| Stout, M | 1 |
| Nikki, P | 1 |
| Vapaatalo, H | 1 |
| Karppanen, H | 1 |
1 review available for 5-hydroxytryptophan and Tremor
| Article | Year |
|---|---|
Monoamine precursors and analogues.
Topics: 5-Hydroxytryptophan; Animals; Biogenic Amines; Dihydroxyphenylalanine; Dopamine beta-Hydroxylase; Dr | 1975 |
2 trials available for 5-hydroxytryptophan and Tremor
| Article | Year |
|---|---|
The treatment of depression with L-5-hydroxytryptophan versus imipramine. Results of two open and one double-blind study.
Topics: 5-Hydroxytryptophan; Adult; Clinical Trials as Topic; Depression; Double-Blind Method; Drug Synergis | 1977 |
Administration of 5-hydroxy-L-tryptophan to individuals with Huntington's chorea.
Topics: 5-Hydroxytryptophan; Adult; Brain; Evaluation Studies as Topic; Female; Humans; Huntington Disease; | 1972 |
47 other studies available for 5-hydroxytryptophan and Tremor
| Article | Year |
|---|---|
Effect of dichloromethane fraction of Areca catechu nut on monoamines associated behaviors and tyramine pressor sensitivity in rodents.
Topics: 5-Hydroxytryptophan; Animals; Areca; Behavior, Animal; Biogenic Monoamines; Blood Pressure; Dopamine | 2014 |
5-HT precursor loading, but not 5-HT receptor agonists, increases motor function after spinal cord contusion in adult rats.
Topics: 5-Hydroxytryptophan; Animals; Carbidopa; Cervical Vertebrae; Disease Models, Animal; Dose-Response R | 2010 |
[Action of different inhibitors of L-DOPA 5 HTP decarboxylase on insulin hypoglycemia in the rat].
Topics: 5-Hydroxytryptophan; Animals; Antihypertensive Agents; Antimetabolites; Cinnamates; Dopa Decarboxyla | 1963 |
EFFECT OF ALPHA METHYL DOPA ON EXPERIMENTAL TREMOR.
Topics: 5-Hydroxytryptophan; Atropine; Electrophysiological Phenomena; Electrophysiology; Equipment and Supp | 1963 |
THE EFFECT OF L-3, 4-DIHYDROXYPHENYLALANINE AND DL-5-HYDROXYTRYPTOPHAN ON RIGIDITY AND TREMOR INDUCED BY RESERPINE, CHLORPROMAZINE AND PHENOXYBENZAMINE.
Topics: 5-Hydroxytryptophan; Amino Acids; Chlorpromazine; Dihydroxyphenylalanine; Dopamine; Inulin; Movement | 1964 |
EFFECT OF SOME BENZYLHYDRAZINES AND BENZYLOXYAMINES ON DOPA AND 5-HYDROXYTRYPTOPHAN DECARBOXYLASE IN VIVO.
Topics: 5-Hydroxytryptophan; Amines; Aromatic-L-Amino-Acid Decarboxylases; Carbon Isotopes; Carboxy-Lyases; | 1964 |
R-citalopram inhibits functional and 5-HTP-evoked behavioural responses to the SSRI, escitalopram.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Citalopram; Corticosterone; Dose-Response Relationsh | 2004 |
In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
Topics: 5-Hydroxytryptophan; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Avoidance Lea | 2006 |
Pharmacological characteristics of abnormal behavior induced by harmine with special reference to tremor in mice.
Topics: 5-Hydroxytryptophan; Alkaloids; Animals; Antidepressive Agents; Behavior, Animal; Diazepam; Disease | 1981 |
Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats.
Topics: 5-Hydroxytryptophan; Adrenergic Uptake Inhibitors; Amitriptyline; Animals; Antidepressive Agents; Be | 1995 |
Evaluation of a ginkgo biloba extract (EGb 761) in functional tests for monoamine oxidase inhibition.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Dopamine Agents; Dose-Response Relationship, Drug; D | 2000 |
Experimental data suggesting an adrenergic mechanism in the production of parkinsonian symptoms.
Topics: 5-Hydroxytryptophan; Animals; Atropine; Clonidine; Female; Fenclonine; Imipramine; Male; Mice; Mice, | 1976 |
Cataleptic effect of 61-91 beta-lipotropic hormone in rat.
Topics: 5-Hydroxytryptophan; Animals; beta-Lipotropin; Catalepsy; Catatonia; Dose-Response Relationship, Dru | 1977 |
New approaches in the management of hyperkinetic movement disorders.
Topics: 5-Hydroxytryptophan; Carbidopa; Chorea; Dyskinesia, Drug-Induced; Humans; Movement Disorders; Myoclo | 1977 |
Changes in motor behavior following the administration of serotonin neurotoxins.
Topics: 5-Hydroxytryptophan; 5,7-Dihydroxytryptamine; Animals; Desipramine; Motor Activity; Myoclonus; p-Chl | 1978 |
Serotonin-norepinephrine interactions in the tremorolytic actions of phenoxybenzamine and trazodone.
Topics: 5-Hydroxytryptophan; Animals; Male; Mice; Norepinephrine; Phenoxybenzamine; Piperazines; Serotonin; | 1979 |
Application of 5 HTP in the treatment of essential tremor.
Topics: 5-Hydroxytryptophan; Humans; Tremor | 1979 |
Myoclonus after 5-hydroxytryptophan in rats with lesions of indoleamine neurons in the central nervous system.
Topics: 5-Hydroxytryptophan; Animals; Benserazide; Brain; Dose-Response Relationship, Drug; Drug Interaction | 1976 |
Behaviors induced by 5-hydroxytryptophan in neonatal, preweaning, postweaning, and adult Sprague-Dawley rats.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Aging; Amphetamines; Animals; Animals, | 1992 |
5-HT1A and 5-HT2 receptors mediate discrete behaviors in the Mongolian gerbil.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Interactions; | 1992 |
Studies with new ergoline derivatives on the effects of central and peripheral 5-hydroxytryptamine receptors.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Brain; Ergolines; In Vitro Techniques; Ketanserin; M | 1992 |
Interaction of central serotonin and dopamine in the regulation of carbaryl-induced tremor.
Topics: 5-Hydroxytryptophan; Acetylcholinesterase; Animals; Atropine; Behavior, Animal; Brain Chemistry; Bro | 1990 |
Comparison of clenbuterol enantiomers using four psychopharmacological tests sensitive to beta-agonists.
Topics: 5-Hydroxytryptophan; Adrenergic beta-Agonists; Animals; Apomorphine; Behavior, Animal; Body Temperat | 1985 |
Central beta-adrenoceptors can modulate 5-hydroxytryptamine-induced tremor in rats.
Topics: 5-Hydroxytryptophan; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Clenbuterol; Ma | 1986 |
Involvement of beta 2-adrenoceptor blockade and 5-hydroxytryptamine mechanism in inhibition of harmaline-induced tremors in rats.
Topics: 5-Hydroxytryptophan; Acebutolol; Adrenergic beta-Antagonists; Alkaloids; Animals; Butoxamine; Female | 1986 |
Blockade of central beta-adrenoceptors attenuates tremor induced by 5-hydroxytryptamine (5-HT)-receptor activation in rats.
Topics: 5-Hydroxytryptophan; Adrenergic beta-Antagonists; Animals; Dose-Response Relationship, Drug; Male; M | 1987 |
Objective quantification of tremor in conscious unrestrained rats, exemplified with 5-hydroxytryptamine-mediated tremor.
Topics: 5-Hydroxytryptophan; Animals; Carbidopa; Dose-Response Relationship, Drug; Male; Pargyline; Rats; Ra | 1985 |
Effects of triiodothyronine on the 5-hydroxytryptophan-induced head twitch and its potentiation by antidepressants in mice.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Clenbuterol; Dose-Response Relationship, Drug; | 1985 |
Harmine-, LON-954- and 5-hydroxytryptophan-induced tremors in rats withdrawn from ethanol.
Topics: 5-Hydroxytryptophan; Alkaloids; Animals; Ethanol; Harmine; Male; Physostigmine; Rats; Rats, Inbred S | 1985 |
5-hydroxytryptophan in parkinsonism.
Topics: 5-Hydroxytryptophan; Aged; Female; Humans; Male; Middle Aged; Parkinson Disease; Tremor | 1970 |
Effect of L-5HTP on tremorine- or oxotremorine-induced tremor in mice and rats.
Topics: 5-Hydroxytryptophan; Animals; Atropine; Drug Synergism; Fenclonine; Male; Mice; Oxotremorine; Rats; | 1973 |
Mechanisms of tremor induction by harmine.
Topics: 5-Hydroxytryptophan; Alkaloids; Animals; Biogenic Amines; Depression, Chemical; Dopamine; Dose-Respo | 1974 |
Serotonergic and antiserotonergic influences on amphetamine-induced stereotyped behavior.
Topics: 5-Hydroxytryptophan; Acetylcholine; Animals; Basal Ganglia Diseases; Behavior, Animal; Corpus Striat | 1973 |
[L-5-hydroxytryptophan(L-5-HTP) therapy of Parkinson's disease. 2].
Topics: 5-Hydroxytryptophan; Adult; Aged; Depression; Dihydroxyphenylalanine; Female; Humans; Male; Middle A | 1972 |
Antagonism of tremorine-induced tremor by serotoninergic agents in mice. Interactions with levodopa.
Topics: 5-Hydroxytryptophan; Animals; Atropine; Benztropine; Dihydroxyphenylalanine; Dose-Response Relations | 1972 |
HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Chorea; Dopamine; Dystonia Musculorum Deformans; Femal | 1973 |
5-Hydroxytryptophan induced behavior in intact guinea pigs.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Guinea Pigs; Humans; Male; Stereotyped Behavior; Tre | 1973 |
Effect of 5-hydroxytryptophan on brain levels of dopamine, norepinephrine, and serotonin in mice.
Topics: 5-Hydroxytryptophan; Animals; Brain; Brain Chemistry; Dopamine; Male; Mice; Mice, Inbred ICR; Motor | 1974 |
Tremor and involuntary movements in monkeys: effect of L-dopa and of a dopamine receptor stimulating agent.
Topics: 5-Hydroxytryptophan; Animals; Benzyl Compounds; Dihydroxyphenylalanine; Dioxoles; Drug Interactions; | 1973 |
The effects of centrally acting drugs on tremor in monkeys with mesencephalic lesions.
Topics: 5-Hydroxytryptophan; Animals; Atropine; Dihydroxyphenylalanine; Disease Models, Animal; Drug Synergi | 1969 |
Drug-induced relief of experimental tremor in monkeys.
Topics: 5-Hydroxytryptophan; Animals; Basal Ganglia; Brain Stem; Dihydroxyphenylalanine; Disease Models, Ani | 1970 |
Evaluation of anti-tremor drugs in tremor-induced rodents.
Topics: 5-Hydroxytryptophan; Alkaloids; Amino Alcohols; Animals; Anticonvulsants; Chlorisondamine; Chlorprom | 1965 |
Psychoactive agents in dogs with bilateral lesions in subcortical structures.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Caudate Nucleus; Dogs; Movement Disorders; Quinoline | 1968 |
The effect of 5-hydroxytryptamine and 5-hydroxytryptophan on extra-pyramidal function.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Basal Ganglia; Behavior, Animal; Dihydroxyphenylalanine; | 1969 |
Abnormal movements and rigidity induced by harmaline in relation to striatal acetylcholine, serotonin, and dopamine.
Topics: 5-Hydroxytryptophan; Acetylcholine; Alkaloids; Animals; Basal Ganglia; Brain Chemistry; Caudate Nucl | 1970 |
Psychoactive agents in dogs with bilateral lesions in subcortical structures.
Topics: 5-Hydroxytryptophan; Animals; Caudate Nucleus; Chlorpromazine; Dogs; Dopamine; Haloperidol; Hippocam | 1971 |
Effect of ethanol on body temperature, postanaesthetic shivering and tissue monoamines in halothane-anaesthetized rats.
Topics: 5-Hydroxytryptophan; Adrenal Glands; Anesthesia; Animals; Body Temperature; Body Temperature Regulat | 1971 |